eli lilly retatrutide trial Lilly's tirzepatide showed positive results in late-stage as treatment for heart failure Retatrutide, Eli Lilly's next generation

Imagine a medication that helps you control hunger, lose weight sustainably, and improve your metabolic health

Lesman, D., Rodriguez, Y., Rajakumar, D

Common outcomes include: Gradual and sustainable weight loss Noticeable appetite reduction Improved portion control Fewer cravings Better metabolic stability Oral GLP-1 therapy is not one-size-fits-all

During mealtime, the network presented in this study driven by OB GLP-1R may contribute to a decrease in SNS activity, and thus participate in the increase of glucose-induced insulin secretion, in concert with systemic GLP-1 and the GLP-1 dependent neuronal circuitry of the brainstem and hypothalamus recruited under normal physiological circumstances